|

Nelarabine Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: 2-Amino-6-methoxypurine arabinoside, 506U78, ARRANON, Arranon, Atriance +2 more

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

  • University of Chicago1
  • St. Jude Children's Research Hospital1
  • M.D. Anderson Cancer Center1

Indications

  • Cancer3
  • T Acute Lymphoblastic Leukemia1
  • T-lymphoblastic Lymphoma1
  • T - Cell Lymphoma1
  • Leukemia1

San Diego, California1 trial

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

Rady Children's Hospital

Phase 2

Chicago, Illinois1 trial

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

University of Chicago Medicine Comprehensive Cancer Center

Phase 1/2

Houston, Texas1 trial

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.